Logo Logo Logo Logo Logo
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News
  • Home
  • Science
    • Scientific Advisory Board
    • Competitive Advantage
    • Patent Groups
    • Biopharma Pipeline
    • Research Partners
  • Team
  • Investors
    • Press Releases
    • SEC Filings
  • Contact
    • Sign up for News

Media

27 June, 2018 in GB Sciences, Media, Press Release, Science
GB Sciences Files New Provisional Patent
26 June, 2018 in GB Sciences, Media, Press Release, Science
GB Sciences Files New Patents
21 June, 2018 in CEO John Poss, Media, Partners, Science
Radio Interview: John Poss on Bill Martinez Live
15 May, 2018 in CEO John Poss, Media, Partners, Science
Video: CEO John Poss talks European Trials
15 May, 2018 in CEO John Poss, Media, Partners, Science
Video: CEO John Poss talks Rec vs. Science
15 May, 2018 in CEO John Poss, Media, Partners, Science
Video: CEO John Poss talks CBD, Cura, Hemp
30 April, 2018 in Media
CNN: Patients turn to pot over pills
18 April, 2018 in GB Sciences, Media, Press Release, Science
GB Seeks Minor Cannabinoids for Patient Studies
16 April, 2018 in Media
Louisiana House backs expansion of medical cannabis program
13 April, 2018 in CEO John Poss, GB Sciences, Media, Partners, Science
Video: CEO John Poss on a “Small but Complex” Company
  • 1
  • 2
  • 3
  • 4

GBSciences, Inc.

Next generation cannabinoid research and development.